Jacobs Levy Equity Management’s Nuvation Bio NUVB Stock Holding History

Jacobs Levy Equity Management’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.04M	Buy	+534,759	New	+$2.61M	0.01%	513
2024 Q3	–	Sell	-1,281,376	Closed	-$3.74M	–	1024
2024 Q2	$3.74M	Buy	1,281,376 +532,583	+71%	+$1.63M	0.02%	494
2024 Q1	$2.73M	Buy	748,793 +537,314	+254%	+$1.03M	0.01%	547
2023 Q4	$319K	Sell	211,479 -547,663	-72%	-$705K	﹤0.01%	881
2023 Q3	$1.02M	Buy	759,142 +244,558	+48%	+$407K	0.01%	676
2023 Q2	$926K	Buy	514,584 +430,156	+509%	+$731K	0.01%	709
2023 Q1	$140K	Buy	+84,428	New	+$171K	﹤0.01%	923

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DFO

Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Jacobs Levy Equity Management's NUVB Position: Q2 2026 in Review

Jacobs Levy Equity Management opened a new position in Nuvation Bio (NUVB) in Q2 2026: 534,759 shares worth $3.04M. The stake represents 0.01% of the portfolio and ranks #513 among its holdings. This is a return to the name: Jacobs Levy Equity Management previously reported a position in NUVB as recently as Q2 2024.

Jacobs Levy Equity Management first reported a position in NUVB in Q1 2023 and has held it in 7 quarters since. The position peaked at $3.74M in Q2 2024. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

Jacobs Levy Equity Management held 534,759 shares of Nuvation Bio worth $3.04M as of Q2 2026.
Nuvation Bio was a new Jacobs Levy Equity Management position in Q2 2026.
Nuvation Bio made up 0.01% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #513 holding.
Jacobs Levy Equity Management first reported a position in Nuvation Bio in Q1 2023 and has held it in 7 quarters since.
Jacobs Levy Equity Management's Nuvation Bio position peaked at $3.74M in Q2 2024.
244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.